123ArticleOnline Logo
Welcome to 123ArticleOnline.com!
ALL >> General >> View Article

Cordenpharma Invests $900m In Usa & Europe Peptide Expansion

Profile Picture
By Author: Ben Gross
Total Articles: 433
Comment this article
Facebook ShareTwitter ShareGoogle+ ShareTwitter Share

CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its Peptide technology platform. These transformational plans consist of two major expansion initiatives occurring in parallel in the US and Europe, including both existing facilities and new constructions designed and built according to the pharmaceutical industry's most stringent quality and technical standards for short and long peptide manufacturing, including Biologics License Applications (BLA) requirements.

The US expansion involves bringing additional Peptide capacity to the CordenPharma Colorado site with the planned construction of a new large-scale manufacturing facility, and an additional increase in manufacturing trains in the existing facility. This is the result of rapidly increasing demand in the Diabetes and Obesity Glucagon-like Peptide 1 (GLP-1) agonist medications market, and comes off the back of multiple, long-term, multiyear contracts totaling ~€3bn, with potential upsides.
The European expansion centers on the construction of a new state-of-the-art greenfield ...
... facility, with the aim of creating additional Peptide capacity to serve customers from initial early clinical to late-stage commercial manufacturing. The new site will be located in the heart of Europe, fully-integrated within CordenPharma's existing facility network.

In 2022, CordenPharma was acquired by Astorg, a leading Pan-European private equity firm, and its ambitious growth plans aim to help the company reach their ~€1bn sales mark for its pioneering Peptide Platform, and ~€1.8bn total group revenue by 2028. Upon completion, the new constructions will be fully integrated within its outstanding network of world-class cGMP manufacturing facilities, along with the dedicated technical and regulatory support by expert teams needed to secure innovators' supply chains with small to large-scale fully-integrated services from APIs to Drug Products.

More Information : https://www.techdogs.com/tech-news/pr-newswire/cordenpharma-invests-900m-in-transformational-peptide-platform-expansion-in-the-usa-europe

Total Views: 39Word Count: 280See All articles From Author

Add Comment

General Articles

1. Subkuz Hindi News Online Platform
Author: Subkuz

2. Exploring Lingerie Trends In Australia: What Brides Need To Know
Author: Jaime Murphy

3. Dental Care Abu Dhabi
Author: Aldana

4. How To Select The Best Food Delivery App Development Company For Lasting Success
Author: Elite_m_commerce

5. Caravan Booking In Delhi: A Guide To Renting Your Mobile Home For Adventure And Comfort
Author: CaravanHireinDelhiNCR

6. Video Box Pricing – Understanding The Value Of Video Plus Print
Author: videoplusprint

7. Unlock Your Digital Potential With Expert Web Development Services
Author: garvirediwal

8. Expressgiftbasketsusa – Premium Chocolate Gift Baskets Delivered Anywhere In The Usa!
Author: Sankar Roy

9. Electromechanical Companies In Uae On Tradersfind
Author: abdulkhan

10. Medical Translation Dubai: English, Arabic & More
Author: nooralhiba

11. Book Now Best Dubai Holiday Tour Package From India At Best Prices
Author: YATIKA

12. Leverage Web Scraping Service For Grocery Store Location Data
Author: iwebdatascraping

13. Wifi Connection In Tiruchendur | Sathya Fibernet
Author: Sathya Fibernet

14. Cit Exam: Certified Instructional Trainer Guide
Author: Komal

15. Community Solar Programs: How They Work And Their Benefits
Author: blogswalaindia

Login To Account
Login Email:
Password:
Forgot Password?
New User?
Sign Up Newsletter
Email Address: